Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PALI | AMGN | BMY | GILD | VRTX |
| Company | Palisade Bio Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.6600 | 325.58 | 54.52 | 123.80 | 435.41 |
| High | 1.9000 | 331.34 | 54.91 | 126.24 | 442.38 |
| Low | 1.6600 | 321.71 | 53.88 | 122.28 | 429.00 |
| Latest | 1.8900 | 331.00 | 54.22 | 124.14 | 442.08 |
| Change | +0.2300 | +0.59 | -1.04 | -0.77 | +0.72 |
| % Change | +13.86% | +0.18% | -1.88% | -0.62% | +0.16% |
| Volume | 14,170,333 | 2,947,093 | 15,348,222 | 9,151,075 | 1,810,791 |
| 20-Day Average Volume | 6,744,031 | 2,763,070 | 14,221,331 | 6,572,585 | 1,418,760 |
| Previous Close | 1.6600 | 330.41 | 55.26 | 124.91 | 441.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0505 | 329.47 | 54.95 | 123.05 | 457.13 |
| 20-Day Raw Stochastic | 25.37% | 51.49% | 43.37% | 68.95% | 22.35% |
| 20-Day Relative Strength | 48.78 | 53.13 | 54.54 | 52.58 | 47.10 |
| Weighted Alpha | -36.32 | +21.09 | -0.28 | +29.45 | +1.55 |
| Today's Opinion | 64% Buy | 80% Buy | 80% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 64% Buy | 64% Buy | 100% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 72% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.53% since 01/12/26 | +1.68% since 01/12/26 | -2.78% since 01/12/26 | +1.26% since 01/12/26 | -4.02% since 01/12/26 |
| Low | 1.6350 on 01/16/26 | 319.79 on 01/13/26 | 53.88 on 01/20/26 | 120.22 on 01/13/26 | 429.00 on 01/20/26 |
| High | 2.0100 on 01/14/26 | 333.03 on 01/16/26 | 57.04 on 01/14/26 | 126.24 on 01/20/26 | 462.42 on 01/13/26 |
| 1-Month | |||||
| %Chg | +3.28% since 12/19/25 | +1.11% since 12/19/25 | +0.06% since 12/19/25 | -0.12% since 12/19/25 | -3.10% since 12/19/25 |
| Low | 1.6350 on 01/16/26 | 318.21 on 01/05/26 | 52.06 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 2.6400 on 12/30/25 | 343.05 on 01/07/26 | 57.04 on 01/14/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +1.61% since 10/20/25 | +9.12% since 10/20/25 | +24.39% since 10/20/25 | +0.84% since 10/20/25 | +5.48% since 10/20/25 |
| Low | 1.5150 on 11/07/25 | 288.00 on 10/31/25 | 42.52 on 10/29/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 2.6400 on 12/30/25 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +151.93% since 07/18/25 | +12.29% since 07/18/25 | +14.48% since 07/18/25 | +14.71% since 07/18/25 | -3.86% since 07/18/25 |
| Low | 0.5300 on 09/11/25 | 269.77 on 09/26/25 | 42.52 on 10/29/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 2.6400 on 12/30/25 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 247,345 | 177,919,520 | 112,495,712 | 154,973,344 | 111,981,408 |
| Shares Outstanding, K | 149,003 | 538,481 | 2,035,753 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 33,424,000,000 | 48,300,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -14,440,000 | 4,090,000,000 | -8,948,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 9,557,000,000 | 12,222,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -2,870,000 | 3,216,000,000 | 2,201,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.43 | 0.45 | 0.29 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 11/10/25 | 5.64 on 11/04/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/23/26 | 02/03/26 | 02/05/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 2.380 on 11/21/25 | 0.630 on 01/02/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/13/26 | 01/02/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.09 | 8.63 | 14.81 | 28.67 |